C F Barker

Author PubWeight™ 148.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 1968 2.60
2 Immunologically privileged sites. Adv Immunol 1977 2.35
3 Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2001 2.27
4 Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 1990 2.25
5 Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet 1984 1.81
6 B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 1997 1.75
7 I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol 1999 1.56
8 Popliteal artery aneurysms: current management and outcome. J Vasc Surg 1994 1.55
9 Magnetic resonance angiography of peripheral runoff vessels. J Vasc Surg 1992 1.45
10 Late failure of reversed vein bypass grafts. Ann Surg 1989 1.41
11 A twenty-two year review of elective resection of abdominal aortic aneurysms. Surg Gynecol Obstet 1976 1.40
12 Living-related donors with bilateral multiple renal arteries. A twenty-year experience. Transplantation 1989 1.28
13 Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J Vasc Surg 2001 1.27
14 The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation 1985 1.26
15 The role of regional lymphatics in the skin homograft response. Transplantation 1967 1.17
16 Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc 1973 1.16
17 Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science 1981 1.16
18 Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats. J Immunol 1983 1.15
19 Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect. Diabetologia 1982 1.10
20 Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 1992 1.10
21 Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am J Surg 1999 1.08
22 Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes 1999 1.05
23 Prevention of diabetes in rats by bone marrow transplantation. Ann Surg 1981 1.05
24 Skeletal muscle as a privileged site for orthotopic skin allografts. J Exp Med 1973 1.04
25 Physiological and immunological consequences of transplanting isolated pancreatic islets. Surgery 1973 1.03
26 Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 2000 1.03
27 Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem. Transplantation 1984 1.02
28 Disseminated mycobacterium kansasii infection presenting as cellulitis in a recipient of a renal homograft. Am Rev Respir Dis 1975 1.01
29 Evidence for major histocompatibility complex restriction in transplantation immunity. Proc Natl Acad Sci U S A 1982 1.01
30 Live cytomegalovirus vaccination of renal transplant candidates. A preliminary trial. Ann Intern Med 1979 1.01
31 Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation 1992 1.01
32 Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol 2001 1.00
33 Studies of the modified venous allograft. Ann Surg 1977 1.00
34 Autoimmunity and type I (insulin-dependent) diabetes mellitus. Transplantation 1983 1.00
35 The antigenicity of venous allografts. Trans Am Soc Artif Intern Organs 1976 0.97
36 Risk of excision of abdominal aortic aneurysms. Surgery 1970 0.97
37 Peripheral arterial embolism. Surg Gynecol Obstet 1966 0.97
38 Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation 1991 0.95
39 Diagnosis and treatment of inferior mesenteric arterial endoleaks after endovascular repair of abdominal aortic aneurysms. Radiology 2000 0.94
40 Induction of donor-specific tolerance to rat cardiac allografts by intrathymic inoculation of bone marrow. Surgery 1992 0.93
41 Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. Ann Surg 1995 0.93
42 Long-term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg 1981 0.93
43 The venous homograft: an immunological question. Surgery 1972 0.93
44 Comparison of the fates of Ag-B locus compatible homografts of skin and hearts in inbred rats. Nature 1970 0.92
45 Canine renal homotransplantation with venous drainage via the portal vein. Ann Surg 1967 0.92
46 Transplantation immunity and delayed cutaneous hypersensitivity reactions in dogs. J Immunol 1967 0.92
47 Successful islet transplantation in spontaneous diabetes. Surgery 1979 0.92
48 Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther 1996 0.91
49 Histocompatibility requirements of heart and skin grafts in rats. Transplant Proc 1971 0.91
50 Lethal post-transplantation calcinosis. Transplantation 1979 0.91
51 Influence of organ culture on the survival of major histocompatibility complex-compatible and incompatible parathyroid allografts in rats. Transplantation 1981 0.90
52 The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression. Transplantation 1990 0.89
53 Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J Immunol 1999 0.89
54 Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995 0.89
55 A direct method for the calculation of alloreactive CD4+ T cell precursor frequency. Transplantation 1999 0.88
56 Immunologic problems in islet transplantation. Diabetes 1980 0.88
57 An unusual variant of membranous nephropathy with abundant crescent formation and recurrence in the transplanted kidney. Clin Nephrol 1978 0.88
58 Lymph node cells: their differential capacity to induce tolerance of heart and skin homografts in rats. Science 1971 0.88
59 Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc Surg 2001 0.88
60 Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell Immunol 1999 0.87
61 Prophylaxis of serious cytomegalovirus infection in renal transplant candidates using live human cytomegalovirus vaccine. Interim results of a randomized controlled trial. Arch Surg 1988 0.87
62 Reconstructive surgery distal to the popliteal trifurcation. Effect on the history of arterial occlusive disease. Arch Surg 1973 0.87
63 Influence of culturing on the survival of major histocompatibility complex-compatible and -incompatible thyroid grafts in rats. J Exp Med 1983 0.87
64 The ureteropyelostomy in human renal transplantation. J Urol 1973 0.87
65 Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 1997 0.87
66 A recent decrease in the time to development of monomorphous and polymorphous posttransplant lymphoproliferative disorder. Transplantation 1992 0.87
67 Acute colitis in the renal allograft recipient. Ann Surg 1976 0.86
68 Influence of islet and bone marrow transplantation on the diabetes and immunodeficiency of BB rats. Metabolism 1983 0.85
69 Gender-related differences in infrarenal aortic aneurysm morphologic features: issues relevant to Ancure and Talent endografts. J Vasc Surg 2001 0.85
70 Treatment of lymphocele in renal allograft recipients. Arch Surg 1985 0.85
71 The lymphatic status of hamster cheek pouch tissue in relation to its properties as a graft and as a graft site. J Exp Med 1971 0.85
72 Failure of endovascular abdominal aortic aneurysm graft limbs. J Vasc Surg 2001 0.85
73 Gamma interferon induces novel expression of Ia antigens by rat pancreatic islet endocrine cells. Pancreas 1987 0.85
74 Immunologic barriers to hepatic adenoviral gene therapy for transplantation. Transplantation 1997 0.85
75 Results of 100 consecutive femoropopliteal vein grafts for limb salvage. Ann Surg 1978 0.84
76 Characterization of the alloimmune response to minor histocompatibility antigens by in vivo MLR. Transplant Proc 1999 0.84
77 Acute appendicitis in the renal allograft recipient. Transplantation 1987 0.84
78 Prevention of diabetes in BB rats by intermittent administration of cyclosporine. Surgery 1987 0.84
79 Carcinogenesis in an immunologically privileged site. J Surg Res 1975 0.83
80 Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody. Diabetes 1988 0.83
81 Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 1993 0.83
82 Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice. Transplantation 1993 0.83
83 Long-term metabolic and immunological considerations in transplantation of pancreatic islets. J Surg Res 1974 0.83
84 The influence of histocompatibility and transplant site on parathyroid allograft survival. J Surg Res 1976 0.83
85 Vulnerability of pancreatic islets to immune cells and serum. Surg Forum 1975 0.82
86 Immunologically competent passenger cells in mouse skin. Transplantation 1972 0.82
87 "Activated" T-lymphocyte levels in the spontaneously diabetic BB rat syndrome. Surgery 1985 0.82
88 Relationship between preoperative patency of the inferior mesenteric artery and subsequent occurrence of type II endoleak in patients undergoing endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2000 0.82
89 Percutaneous transluminal angioplasty. The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis. Transplantation 1987 0.82
90 Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 1991 0.82
91 The influence of T-lymphocyte precursor cells and thymus grafts on the cellular immunodeficiencies of the BB rat. Diabetes 1985 0.81
92 Promotion of pancreatic islet allograft survival by intrathymic transplantation of bone marrow. Diabetes 1992 0.81
93 Intrathymic inoculation of donor cells promotes survival of rat orthotopic liver allografts. Transplant Proc 1993 0.81
94 Analysis of local anatomic factors that influence the survival times of pure epidermal and full-thickness skin homografts in guinea pigs. Ann Surg 1972 0.81
95 Percutaneous transluminal angioplasty treatment of renal transplant artery stenosis. Transplantation 1982 0.81
96 Transplantation of the islets of Langerhans and the histocompatibility of endocrine tissue. Diabetes 1975 0.81
97 Discriminating rejection from CMV infection in renal allograft recipients using flow cytometry. Clin Immunol Immunopathol 1989 0.80
98 The role of magnetic resonance angiography for endoprosthetic design. J Vasc Surg 2001 0.80
99 Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality. J Vasc Surg 1994 0.80
100 Islet transplantation in genetically determined diabetes. Ann Surg 1977 0.80
101 Prevention of cytomegalovirus disease by Towne strain live attenuated vaccine. Birth Defects Orig Artic Ser 1984 0.80
102 Femoropopliteal vein grafts for claudication. Analysis of 100 consecutive cases. Ann Surg 1978 0.80
103 Aspergillus thyroiditis. Otolaryngology 1979 0.80
104 The failure of intrathymic transplantation of nonimmunogenic islet allografts to promote induction of donor-specific unresponsiveness. Transplantation 1994 0.80
105 Tracking alloreactive cell division in vivo. Transplantation 1999 0.80
106 Increased incidence of Ia antigen-bearing T lymphocytes in the spontaneously diabetic BB rat. J Immunol 1985 0.80
107 Transplantation of cultured pancreatic islets to BB rats. Surgery 1986 0.80
108 Magnetic resonance angiography of the aorta, iliac, and femoral arteries. Surgery 1994 0.80
109 Magnetic resonance angiography of the aortic arch. J Vasc Surg 1997 0.79
110 Origin, kinetics, and function of chimeric B lymphocytes in liver allografts. Transplantation 1999 0.79
111 Invited commentary: an overview of pancreas transplantation--biologic aspects. Surgery 1982 0.79
112 Inadvertent transplantation of a melanoma. Transplantation 1980 0.79
113 Ureteropyelostomy and ureteroneocystostomy in renal transplantation: postoperative urological complications. J Urol 1977 0.79
114 Importance of weak histocompatibility factors in survival of pancreatic islet transplants. Surg Forum 1977 0.79
115 Effects of a polyclonal anti-TNF antibody on cell-mediated immunity in vivo. Transplant Proc 1991 0.79
116 Normocalcemia thirteen years after successful parathyroid allografting in a recipient of a renal transplant. Surgery 1992 0.79
117 Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation 1989 0.78
118 Pancreatic and islet autotransplantation. Hepatogastroenterology 1990 0.78
119 Improvement of granulocyte adherence and in vivo granulocyte delivery by ascorbic acid in renal transplant patients. Transplantation 1983 0.78
120 Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases. Ann Surg Oncol 1999 0.78
121 Endothelial repopulation in venous allografts. J Surg Res 1975 0.78
122 Analysis of donor age and cold ischemia time as factors in cadaveric human islet isolation. Transplant Proc 1994 0.78
123 Microchimerism of the thymus and graft acceptance. Lancet 1992 0.78
124 Science, specialization, and the American Surgical Association. Ann Surg 1997 0.78
125 Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity. Transplant Proc 1979 0.78
126 Supraceliac aortic pseudoaneurysms after liver transplantation in infants. Transplantation 1999 0.78
127 Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients. Transplant Proc 1995 0.78
128 Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 1998 0.78
129 Promotion of rat cardiac allograft survival by intrathymic inoculation of donor splenocytes. Transplantation 1993 0.78
130 Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Surgery 1994 0.78
131 Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig. Transplantation 1999 0.77
132 Treatment of acute peripheral arterial and graft thromboses with low-dose streptokinase. Surgery 1982 0.77
133 Intrathymic inoculation of islets at birth prevents autoimmune diabetes and pancreatic insulitis in the BB rat. Transplant Proc 1993 0.77
134 Alymphatic skin islands: a murine model. J Surg Res 1977 0.77
135 Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells. Transplantation 1993 0.77
136 Physiologic and immunologic status of long-functioning transplanted pancreatic islets in rats. Surg Forum 1974 0.77
137 Inhibition of virus-induced murine diabetes by an interferon inducer. J Interferon Res 1982 0.77
138 Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow. Ann Surg 1993 0.77
139 Allograft rejection by T cell receptor transgenic mice. J Surg Res 1993 0.77
140 Adverse effect of splenectomy on the survival of patients with more than one kidney transplant. Transplantation 1986 0.77
141 Bilateral complete ureteral obstruction secondary to an abdominal aortic aneurysm with perianeurysmal fibrosis: diagnosis by computed tomography. J Urol 1979 0.77
142 Islet endocrine cell MHC antigen expression in allograft rejection. Transplant Proc 1990 0.77
143 Effect of lymphokine-induced MHC antigen expression on islet allograft survival. Transplant Proc 1989 0.77
144 Vulnerability of allogeneic and xenogeneic pancreatic islets to alloantisera. Transplant Proc 1977 0.77
145 Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients. Transplant Proc 1993 0.77
146 Pioneering work in immune tolerance. Science 1992 0.77
147 Granulocyte function in recipients of renal transplant from live related donors and from cadavers. J Infect Dis 1980 0.77
148 In vivo MLR: a novel method for the study of alloimmune responses. Transplant Proc 1999 0.77
149 Differential susceptibility of endocrine tissues to humoral immunity. Surg Forum 1978 0.77
150 Direct assessment of the role of NK cells in autoimmune diabetes. J Surg Res 1992 0.76
151 Skin homografts in vascularized skin pedicles in guinea pigs. Surg Forum 1966 0.76
152 Studies of the immediately vascularized skin allograft. Br J Surg 1980 0.76
153 Intrathymic islet transplantation in the spontaneously diabetic BB rat. Ann Surg 1991 0.76
154 Vascularized pancreas versus isolated islet allografts: an immunological comparison. Surgery 1980 0.76
155 Mycobacterial infections in renal allograft recipients. Arch Surg 1983 0.76
156 Prolongation of survival of donor-strain islet xenografts (rat-->mouse) by intrathymic inoculation of xenogeneic islet and bone marrow cells. Transplantation 1994 0.76
157 B lymphocytes influence the shape of the mature preimmune CD4+ TCR repertoire. Transplant Proc 1999 0.76
158 The immediately vascularized skin allograft. Transplantation 1979 0.76
159 Perspectives in pancreatic and islet transplantation. N Engl J Med 1992 0.75
160 Cell-mediated immunity in type I (insulin-dependent) diabetes of man and the BB rat. Concepts Immunopathol 1985 0.75
161 Influence of histocompatibility and transplant site on survival. Ann Surg 1978 0.75
162 "Cluster" allografts. J Am Coll Surg 1995 0.75
163 Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens. Transplant Proc 1997 0.75
164 Animal models of diabetes and immunological problems with islet allografts. Trans Am Soc Artif Intern Organs 1982 0.75
165 The nonvisualized nonoccluded graft. AJR Am J Roentgenol 1983 0.75
166 Beta-cell replacement. Diabetologia 1997 0.75
167 Effect of selective depletion of donor CD8+ lymphocytes on graft-versus-host disease in small-bowel transplantation. Transplant Proc 1990 0.75
168 Immunologic studies of the prediabetic stage in the spontaneous autoimmune diabetes mellitus of the BB rat. Transplantation 1985 0.75
169 Cytomegalovirus vaccination and renal transplantation. Lancet 1978 0.75
170 Alymphatic pedicles. Lymphology 1981 0.75
171 Donor antigen-specific T-lymphocyte deletion after intrathymic inoculation. Transplant Proc 1993 0.75
172 Numerical and functional abnormaLity of T suppressor cells in diabetic rats. Surgery 1983 0.75
173 Thymus allografts fail to improve lymphopenia or prevent autoimmune diabetes in the BB rat. Transplant Proc 1989 0.75
174 Effect of spontaneous diabetes on hormone release in BB/Phi rats: comparison between the isolated perfused pancreas/stomach/duodenum/spleen and the isolated perfused pancreas. Endocrinology 1983 0.75
175 Percutaneous transluminal angioplasty and fibrinolytic therapy for renal allograft arterial stenosis and thrombosis. Transplantation 1982 0.75
176 Use of the vascular stapling device in procurement of the pancreatic allograft. Surg Gynecol Obstet 1990 0.75
177 Role of humoral immunity in pancreatic islet allo- and xenograft rejection. Transplant Proc 1996 0.75
178 Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment. Transplantation 1992 0.75
179 The influence of removing passenger cells on the fate of skin and parathyroid allografts. Evidence for major histocompatibility complex restriction in transplantation immunity. Diabetes 1982 0.75
180 Renal transplantation for end-stage myeloma kidney: report of a patient with long-term survival. Arch Surg 1979 0.75
181 Murine CD2 mediates cellular immune responses in vivo. Transplant Proc 1991 0.75
182 Effect of culture in 95% O2 on the survival of parathyroid allografts. Surg Forum 1979 0.75
183 Fetal pancreas in treatment of experimental diabetes in rats. Transplant Proc 1979 0.75
184 Fetal pancreas in treatment of experimental diabetes in rats. Curr Surg 1981 0.75
185 Dependence of antilymphocyte serum effectiveness on degree of donor-recipient histocompatibility. Surg Forum 1972 0.75
186 Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts. Transplant Proc 1995 0.75
187 Extension of skin homograft survival by prevention of graft-host skin contact. Transplant Proc 1973 0.75
188 Variable response to donor-specific blood transfusion in the rat. Transplantation 1984 0.75
189 The effect of phenobarbital and methylprednisolone on the biotransformation of cyclosporine in the rat. Transplant Proc 1988 0.75
190 Basic and clinical considerations in the use of xenografts. Curr Probl Surg 1994 0.75
191 Effect of histocompatibility and transplant site in thyroid allograft survival. Surg Forum 1977 0.75
192 Prevention of autoimmune damage to islet grafts in BB rats by antibody therapy. Transplant Proc 1989 0.75
193 Enhancement of whole pancreas and islet allografts. Transplant Proc 1981 0.75
194 Induction of tolerance in rats by treatment with antithymocyte serum and adult skin homografts. J Surg Res 1973 0.75
195 Nutritional support in renal failure. Surg Clin North Am 1991 0.75
196 Recent developments in transplantation immunology. II. Plast Reconstr Surg 1969 0.75
197 Relapse of pneumonia caused by cytomegalovirus in two recipients of renal transplants. J Infect Dis 1979 0.75
198 Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats. Transplantation 1991 0.75
199 Lymphatics and homograft reaction and the role of peripheral sensitization. Adv Biol Skin 1971 0.75
200 Effectiveness of antilymphocyte serum as a function of histocompatibility. J Surg Res 1975 0.75
201 Islet transplantation in spontaneously diabetic rats. Transplant Proc 1981 0.75
202 Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes. Transplant Proc 1993 0.75
203 Prolonged survival of class I deficient mouse islet allografts but not xenografts. Transplant Proc 1994 0.75
204 Immunoprediction of diabetes and evaluation of pancreatic islet transplantation during the prediabetic period. Surgery 1988 0.75
205 [Effect of autoimmune destruction and rejection on the function of transplanted islands of Langerhans in spontaneous diabetes in the BB rat]. Immun Infekt 1987 0.75
206 Regional lymphatics and the mechanism of action of neuraminidase. Surg Forum 1973 0.75
207 Successful islet transplantation in the thymus of spontaneously diabetic BB rats. Transplant Proc 1992 0.75
208 Organ transplantation in the twenty-first century. Urol Clin North Am 1998 0.75
209 The influence of donor-recipient histocompatibility on the efficacy of anti-lymphocyte serum. Rev Surg 1973 0.75
210 Acute renal allograft rejection: difficulty in diagnosis of histologically mild cases by MR imaging. J Comput Assist Tomogr 1987 0.75
211 The role of the implant site in rat fetal pancreas transplantation. Trans Am Soc Artif Intern Organs 1977 0.75
212 Cellular requirements for pancreatic islet xenograft rejection. Transplant Proc 1995 0.75
213 Carcinogenesis in immunologically privileged sites. Fed Proc 1978 0.75
214 Studies of prediabetes in the spontaneously diabetic BB rat. Adv Exp Med Biol 1988 0.75
215 Impact of changes in practice patterns on surgical research. Arch Surg 1995 0.75
216 The contribution of MHC antigen modulation to islet allograft rejection. Horm Metab Res Suppl 1990 0.75
217 Functional ureteral obstruction and massive diuresis following renal homotransplantation. J Urol 1972 0.75
218 Susceptibility to diabetogenic virus: host versus pancreatic factors. J Surg Res 1980 0.75
219 Pancreatic islet cells in management of diabetes. Transplant Proc 1977 0.75
220 The importance of immunologic factors in the pathogenesis of encephalomyocarditis virus induced diabetes in mice. Behring Inst Mitt 1984 0.75
221 Engraftment and function of intrathymic pancreatic islet autografts in dogs. Transplant Proc 1995 0.75
222 Post-transplantation lymphocyst: use of ultrasound as adjunct in diagnosis. Urology 1976 0.75
223 Immunomodulation of pre-diabetes in BB rats for prevention of the disease. Adv Exp Med Biol 1988 0.75
224 Human trials: cell and organ transplantation/other therapeutic approaches--summary and discussion. Birth Defects Orig Artic Ser 1980 0.75
225 Tumor transplants in alymphatic skin islands. Surg Forum 1972 0.75
226 Is induction therapy necessary for successful simultaneous pancreas and kidney transplantation in the cyclosporine era? Transplant Proc 1994 0.75
227 An innovative site for fetal pancreas transplantation in rats--the subserosa of a U loop of small intestine. Transplantation 1989 0.75
228 Studies of host immunomodulation and prevention of pancreatic beta cell destruction. Transplant Proc 1990 0.75
229 Recent developments in transplantation immunology. I. Plast Reconstr Surg 1969 0.75
230 Islet xenografts in mice and rats: II. Mixed islet-spleen cell assay to analyze nitric oxide production and inhibition in xenogeneic species combinations. Transplant Proc 1994 0.75
231 Transplantation of islets and bone marrow cells to animals with immune insulitis. Diabetes 1982 0.75
232 Prevention of recurrent diabetes in BB rats after islet transplantation by monoclonal antibody therapy. Diabetes 1989 0.75
233 Transplantation of syngeneic and xenogeneic pancreatic islets in genetically diabetic mice. Surg Forum 1976 0.75
234 Intrathymic transplantation promotes survival of islet xenografts (rat-->mouse). Transplant Proc 1994 0.75
235 Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat. Transplant Proc 1991 0.75
236 The fate of bypass grafts to angiographically occult runoff vessels detected by magnetic resonance angiography. J Vasc Surg 1996 0.75
237 Elevated levels of a lymphocyte subset accurately predict the diabetic state in the BB rat. Pancreas 1987 0.75
238 Subcutaneous fasciotomy--description of a new technique and instrument. Surgery 1966 0.75
239 The effect of general and local intestinal hypothermia on the production and absorption of ammonia. Surgery 1966 0.75
240 Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness. Transplant Proc 1990 0.75
241 Immunologic factors in pathogenesis and treatment of human and animal diabetes. World J Surg 1984 0.75
242 Comparison of activation requirements and activation phenotype of allogeneic and xenogeneic rodent responses in vivo and in vitro. Transplantation 2001 0.75
243 In vitro assessment of human islets for transplantation: a comparison of glucose-stimulated insulin secretion from short-term-cultured (< 48 hours) versus long-term-cultured (> 72 hours) human islets. Transplant Proc 1994 0.75
244 Immunologic consequences of islet MHC antigen modulation in autoimmune diabetes. Transplant Proc 1990 0.75
245 Susceptibility to murine viral diabetes: host versus intrinsic pancreatic factors. Transplant Proc 1981 0.75
246 Thymic major histocompatibility complex antigen expression and suppressor cell sparing by cyclosporine. Transplant Proc 1987 0.75
247 Intraportal FK 506 improves intrahepatic islet allograft survival. Transplant Proc 1991 0.75
248 Immunobiology of the allograft response. Diabetes Metab Rev 1987 0.75
249 Survival of H-Y-incompatible endocrine grafts in mice and rats. Transplantation 1981 0.75
250 Noninvasive evaluation of bladder-drained whole pancreaticoduodenal transplants with magnetic resonance angiography. Transplant Proc 1994 0.75
251 Surgical options for live-donor nephrectomy. Transplant Proc 2001 0.75
252 The in vitro immunogenicity of antigen-presenting cell-free endocrine cells: the role of antigen presenting cells. Transplant Proc 1991 0.75
253 Effectiveness of azathioprine in extending vein homograft survival. J Cardiovasc Surg (Torino) 1973 0.75
254 Influence of culturing on the functioning of major-histocompatibility-complex-compatible and incompatible islet grafts in diabetic mice. Transplantation 1983 0.75
255 Annual literature review--clinical transplants 2000. Clin Transpl 2000 0.75
256 Studies of the venous homograft. Surg Forum 1972 0.75
257 Further studies of the hamster's cheek pouch as a privileged site. Transplant Proc 1969 0.75
258 Islet transplantation to study autoimmune pathogenesis of diabetes in BB rat. Horm Metab Res Suppl 1990 0.75